Stop Calling Everything an Organoid! – 3D Cell Culture Terminology
Griffin Ferrara2021-06-05T18:25:46-05:00As a company focused on 3D cell culture models and assays, we routinely have researchers ask us about organoid [...]
Liver Steatosis: 2D and 3D Screening Platforms
Griffin Ferrara2021-06-05T18:09:58-05:00Steatosis is characterized by abnormal retention of lipids within an organ and is most common within the liver due to [...]
Visikol Joins CELLINK
Griffin Ferrara2021-05-21T08:39:40-05:00May 20th, 2021 - Today Visikol joins the CELLINK family through acquisition. The acquisition provides CELLINK the opportunity to [...]
Examining gene expression with RT-qPCR
Griffin Ferrara2021-05-02T09:18:53-05:00At Visikol, our services have grown from our expertise in cell culture, high-content tissue imaging, and advanced digital pathology. [...]
Immune Synapse Assay for T Cell and Tumor Interaction
Griffin Ferrara2021-05-02T09:16:08-05:00The immune system can be broken down into two main parts: innate and adaptive responses. An innate immune response [...]
Using Light Sheet Imaging for Fluorescence Microscopy
Griffin Ferrara2021-04-21T12:50:44-05:00Light sheet fluorescence microscopy (LSFM) is a powerful tool in the life science researcher’s toolkit. While the old histopathology [...]
Cell Painting – Molecular Imaging in Drug Discovery
Griffin Ferrara2021-04-06T13:12:40-05:00Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
Cell-Subtype Selection in the Creation of a 3D Liver Fibrosis Model
Griffin Ferrara2021-03-19T14:18:00-05:00Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Bruker and Visikol Partner to Launch Light-Sheet Imaging Services
Griffin Ferrara2021-03-09T11:15:45-05:00Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]
Visikol Expands Product Portfolio with New Tissue Slicers
Griffin Ferrara2021-03-05T15:42:58-05:00Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]